Purdue Letter Logo Kinam Park Wonders of PLGA Microparticles

 

The first PLGA microparticle formulation for clinical use was introduced in 1989. It is almost 30 years since then, but the technology of making PLGA microparticles remains the same. The PLGA microparticle formulations can deliver drugs for months. This site presents information related to the PLGA microparticle formulations. Those who are involved in the PLGA microparticle formulations are welcome to join a new scientific society, The PLGA Microparticle Community (PMC). If you would like to share information on PLGA microparticles, please contact Kinam Park.

Drugs (APIs) PLGA Types Solvents Microparticle Preparation
   Small molecules
Peptides
Proteins
Clinical Products
L:G Ratio & Molecular Wt
Linear vs, Star-shape
Solvent Solubility
   Drug Interactions
Solvent Type
Solvent Removal Rate
Phase Seperation
Solubility Parameters
Emulsion Methods
Microfabrication Methods
Microcapsules
Sterilization

Experimental Factors MP Characterization Applications Non-MP Formulations
PLGA
Drug
Solvent
Others
Release Profile
Loading Efficiency & Capacity
Drug Distribution
Surface Morphology
Systemic
Local
-
-  
Cylinder
In-Situ Forming Implant
Thermogel
Extrusion

References by Investigators

Diane Burgess

Patrick DeLuca

Kinam Park

Steven Schwendeman

Kerstin Vay

Yan Wang